2xa0
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='2xa0' size='340' side='right'caption='[[2xa0]], [[Resolution|resolution]] 2.70Å' scene=''> | <StructureSection load='2xa0' size='340' side='right'caption='[[2xa0]], [[Resolution|resolution]] 2.70Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[2xa0]] is a 4 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[2xa0]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2XA0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2XA0 FirstGlance]. <br> |
| - | </td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1ysw|1ysw]], [[2w3l|2w3l]], [[1g5m|1g5m]], [[1gjh|1gjh]]</td></tr> | + | </td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[1ysw|1ysw]], [[2w3l|2w3l]], [[1g5m|1g5m]], [[1gjh|1gjh]]</div></td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2xa0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2xa0 OCA], [https://pdbe.org/2xa0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2xa0 RCSB], [https://www.ebi.ac.uk/pdbsum/2xa0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2xa0 ProSAT]</span></td></tr> |
</table> | </table> | ||
== Disease == | == Disease == | ||
| - | [[ | + | [[https://www.uniprot.org/uniprot/BCL2_HUMAN BCL2_HUMAN]] Note=A chromosomal aberration involving BCL2 has been found in chronic lymphatic leukemia. Translocation t(14;18)(q32;q21) with immunoglobulin gene regions. BCL2 mutations found in non-Hodgkin lymphomas carrying the chromosomal translocation could be attributed to the Ig somatic hypermutation mechanism resulting in nucleotide transitions. |
== Function == | == Function == | ||
| - | [[ | + | [[https://www.uniprot.org/uniprot/BCL2_HUMAN BCL2_HUMAN]] Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1).<ref>PMID:18570871</ref> [[https://www.uniprot.org/uniprot/BAX_MOUSE BAX_MOUSE]] Accelerates programmed cell death by binding to, and antagonizing the apoptosis repressor BCL2 or its adenovirus homolog E1B 19k protein. Under stress conditions, undergoes a conformation change that causes translocation to the mitochondrion membrane, leading to the release of cytochrome c that then triggers apoptosis. Promotes activation of CASP3, and thereby apoptosis. BAX deficiency leads to lymphoid hyperplasia and male sterility, because of the cessation of sperm production.<ref>PMID:8358790</ref> <ref>PMID:21060336</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Revision as of 10:48, 13 April 2022
Crystal structure of BCL-2 in complex with a BAX BH3 peptide
| |||||||||||
Categories: Human | Large Structures | Ku, B | Oh, B H | Apoptosis | Cell death
